Physician profile
Eric W Palmer
NPI 1952515553
$334.76
in general payments reported to CMS, 2019-2025
10 companies · $36.01 in 2025
The $36.01 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $17.16 · 2021: $45.75 · 2022: $11.80 · 2023: $27.66 · 2024: $64.64 · 2025: $36.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $128.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $112.70 | 2019 | |
| Boston Scientific Corporation | $38.32 | 2020-2025 | Icefx Cryoablation System |
| Penumbra, INC. | $33.64 | 2021-2025 | Ruby Coil |
| Angiodynamics, INC. | $27.66 | 2023 | Solero |
| Ethicon US, LLC | $25.20 | 2024 | Certus 140 |
| Teleflex LLC | $23.56 | 2021 | |
| Siemens Medical Solutions USA, INC. | $20.51 | 2024 | Somatom Go.Top |
| Cardiovascular Systems INC. | $19.04 | 2019 | |
| Abbott Laboratories | $18.93 | 2024 | Perclose Proglide |
| Medtronic, INC. | $15.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.